Acquisition of Sodium Fluoride and Choline - PET Radiopharmaceuticals

This tender is for the procurement of specific radiopharmaceuticals: Sodium Fluoride and Choline. These substances are used in Positron Emission Tomography (PET) imaging, a crucial diagnostic tool in modern medicine, particularly in oncology for detecting and staging cancer, as well as in neurology and cardiology. Sodium Fluoride is used for bone imaging, while Choline is used for imaging prostate cancer and other conditions. The procurement aims to ensure a stable and reliable supply of these essential diagnostic agents for healthcare facilities. Bidders are expected to be manufacturers or authorized distributors capable of providing high-purity, quality-assured radiopharmaceuticals that meet stringent regulatory and clinical standards. The tender will likely specify the required quantities, purity levels, packaging, and delivery schedules to ensure timely availability for patient scans. This acquisition is vital for supporting diagnostic imaging services and patient care within the healthcare system.

This is a supplies contract in the health and medical services and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 24,067.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.